Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NHT102 in Advanced Non-Small Cell Lung Cancer
NCT07864584Phase 2Not yet recruiting
- Start
- Jan 2027
- Primary completion
- Jul 2029
- Countries
- 1
01
Overview
A Phase 2 trial of azacitidine in non-small cell lung cancer (NSCLC). Planned start Jan 2027; status: not yet recruiting.
02
Drugs
azacitidine
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT07864584.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07864584.